000 01177 a2200325 4500
005 20250513045629.0
264 0 _c19950310
008 199503s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(95)90441-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChakos, M H
245 0 0 _aCaudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine.
_h[electronic resource]
260 _bLancet (London, England)
_cFeb 1995
300 _a456-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aCaudate Nucleus
_xdrug effects
650 0 4 _aClozapine
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aSchizophrenia
_xdrug therapy
700 1 _aLieberman, J A
700 1 _aAlvir, J
700 1 _aBilder, R
700 1 _aAshtari, M
773 0 _tLancet (London, England)
_gvol. 345
_gno. 8947
_gp. 456-7
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(95)90441-7
_zAvailable from publisher's website
999 _c7853314
_d7853314